ISC 2024 | Improvement in thrombolysis care metrics by race and ethnicity

Shumei Man, MD, PhD, Cleveland Clinic, Cleveland, OH, shares an overview of her work looking at the impact of race and ethnicity on the improvement in thrombolysis care metrics achieved within the US Target: Stroke nationwide quality improvement program. Target: Stroke was launched by the American Heart Association/American Stroke Association in 2010, aiming to reduce door-to-needle (DTN) times for eligible patients being treated with thrombolysis. The program went through several phases, each with more ambitious timing targets. The study showed that compared with White patients, Asian, Black, and Hispanic individuals were significantly more likely to present after the 4.5-hour thrombolysis treatment window. After risk adjustment, disparities were also evidence in thrombolysis treatment rates. DTN times significantly improved during the Target:Stroke period across all race-ethnic groups, but Asian, Black, and Hispanic individuals had significantly lower odds of DTN≤60 minutes. This interview took place during the International Stroke Conference 2024 in Phoenix, AZ.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.